Calculus backs the innovators, the experts and the game changers across the fastest growing sectors in the UK – technology, healthcare and the creative industries.
We focus on companies driving innovation, advancing healthcare and creating jobs and opportunities throughout the country.
Arecor partners with Sequel Med Tech on AT278 insulin and raises up to $11m from Ligand, accelerating Phase 2 readiness, extending cash runway to 2027, and positioning for next-generation diabetes care and significant shareholder value creation.
Calculus portfolio company C4X Discovery selects a best-in-class oral IBD candidate, highlighting innovation and value creation in UK biotech.
Here we speak to Richard Moore, Co-Head of Investments, on the key lessons learned and how that informs our investment strategy in the technology space.
Calculus portfolio company Optalitix, a leading insurtech innovator, has announced the expansion of its flagship pricing platform, Optalitix Quote, into the reinsurance market.
